Tissue Diagnostics Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 – 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC785

Introduction

Tissue is a cluster or layer of cells which accomplishes particular function and contains necessary genetic and biological information. Tissue samples are used for cancer analysis, where it captures the biological background of the syndrome. It imitates the presence of cancer by inspecting the tissue sample under microscope by a skilled physician also known as pathologist. Histopathology is a study of syndrome in a tissue which can be cured by small surgeries and open biopsy or surgery. The three major types of tissue diagnosis are Immunohistochemistry (IHC), Hematoxylin and Eosin (H&E), and In situ hybridization. Hence, many kinds of cancer can be cured by using these technologies like breast cancer, gastric cancer, lymphoma, prostate cancer and others.

Market Dynamics

Factor driving the growth of tissue diagnostics market includes improving infrastructure for cancer diagnosis, growing healthcare expenditure, rising incidences of cancer, and technological development and advancements in tissue diagnostics. When compared developing countries to developed countries, there is low health issue awareness due to some factors like low literacy rate, economic factors, etc. which adversely affects the growth of this market in developing countries. Technological development, mandate for better and advanced treatment can boost the growth of this market in near future.

Market Classification

The market can be bifurcated on the basis of product, technology, disease, end user, and geography. By product, tissue diagnostics market can be segmented into consumables and instruments. Consumables can be further bifurcated into antibodies, kits, reagents, probes and instruments are further classified into slide-staining systems, scanners, tissue-processing systems, and others. By technology, tissue diagnostics market can be segmented into in special staining situ hybridization, workflow management immunohistochemistry, and digital pathology. By disease, tissue diagnostics market can be segmented into gastric cancer, breast cancer, lymphoma, non-small cell lung cancer, prostate cancer, and other diseases. By end user, tissue diagnostics market can be segmented intohospitals, pharmaceutical companies, research laboratories, contract research organizations, and among other end users. On the basis of geography, the tissue diagnostics market can be segmented into North America, Latin America, Europe, Middle East & Africa (MEA) and Asia-Pacific.

Report Coverage

Market

Tissue Diagnostics Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

Product, Technology, Disease, End User, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis,

Competitive Analysis, Player Profiling, Value Chain Analysis

 

Market Participants

Some of the major players involved in tissue diagnostics market include F. Hoffmann-La Roche AG, The Danaher Corporation, Thermo Fisher Scientific, Abbott  Laboratories, Agilent Technologies, Sakura Finetek Japan Co., Ltd., Sienna Cancer Diagnostics, Royal Philips N.V., A. Menarini Diagnostics Ltd., Cell Signaling Technology, Enzo Life Sciences, Inc., Master Diagnostica S.L., and TissueGnostics among others.

Market Segmentation

Market By Product

  • Consumables
    • Antibodies
    • Kits
    • Reagents
    • Probes
  • Instruments
    • Slide-staining Systems
    • Scanners
    • Tissue-processing Systems
    • Others

Market By Technology

  • Immunohistochemistry
  • In Situ Hybridization
  • Digital Pathology and Workflow Management
  • Special Staining

Market By Disease

  • Breast Cancer
  • Gastric Cancer
  • Lymphoma
  • Prostate Cancer
  • Non-small Cell Lung Cancer
  • Others

Market By End User

  • Hospitals
  • Pharmaceutical Companies
  • Research Laboratories
  • Contract Research Organizations
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of LATAM
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

 


Related Reports

Medical Nonwoven Disposables Market (By Product: Incontinence Hygiene Products, Surgical Non-woven Products; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Platform) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights Nonwovens are a unique category of textile product enginee

Plastic Surgery Instruments Market (By Type: Handheld Surgical Instruments, Electrosurgical Instruments; By Procedure: Face and Head Procedures, Breast Procedures, Body and Extremities Procedures, Reconstruction Surgeries) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o

Upper Limb Prosthetics Market (By Component: Prosthetic Arm, Prosthetic Wrist, Prosthetic Shoulder, Prosthetic Elbow, Terminal Devices; By Product: Body Powered Prosthetic Devices, Passive Prosthetic Devices, Hybrid Prosthetic Devices, Myoelectric Prosthetic Devices; By Cause: Vascular Disease and Diabetes, Trauma, Cancer; By End Use: Ambulatory Surgical Centers, Hospitals, Prosthetic Clinics) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments.  Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The

MRI-Guided Neurosurgical Ablation Market (By Product: Accessories, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, MRI-guided Radiofrequency Ablation Systems; By End-use: Clinics, Ambulatory Surgical Centers, Hospitals) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights An gr

Self-Monitoring Blood Glucose Devices Market (By Product: Continuous Glucose Monitors, Lancets, Self-monitoring Blood Glucose Meters, Testing Strips; By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes; By End-Use: Home Usage, Hospitals, Diagnostic Clinics & Centers) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes

Ovarian Cancer Diagnostics Market (By Diagnosis Type: Imaging, Biopsy, Blood Test, Others; By Cancer Type: Germ Cell Tumor, Stromal Cell Tumor, Epithelial Tumor, Others; By End-Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction  According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i

Cart Summary